Apimeds Pharmaceuticals US, Inc. Revenue
Apimeds Pharmaceuticals US, Inc. had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Apimeds Pharmaceuticals US, Inc. had annual revenue of 0.00 with ― growth.